Generated: December 14, 2017
DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 206352
« Back to Dashboard
, which is a drug marketed by Bristol Myers Squibb and is included in two NDAs. It is available from six suppliers. There are two patents protecting this drug and three Paragraph IV challenges. Additional details are available on the REYATAZ profile page.
The generic ingredient in REYATAZ is atazanavir sulfate. There are twenty-three drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the atazanavir sulfate profile page.
Summary for 206352
|Formulation / Manufacturing:||see details|
Pharmacology for NDA: 206352
Medical Subject Heading (MeSH) Categories for 206352
Suppliers and Packaging for NDA: 206352
||National Drug Code
||E.R. Squibb & Sons, L.L.C.
||30 PACKET in 1 CARTON (0003-3638-10) > 1 POWDER in 1 PACKET
|Complete Access Available with Subscription
Summary for product number 001
|Active Rx/OTC/Discontinued:||RX||Dosage:||POWDER;ORAL||Strength||EQ 50MG BASE/PACKET|
|Approval Date:||Jun 2, 2014||TE:||RLD:||Yes|
|Regulatory Exclusivity Expiration:||Sep 24, 2018
|Regulatory Exclusivity Use:||NEW PATIENT POPULATION|
|Regulatory Exclusivity Expiration:||Jun 2, 2017
|Regulatory Exclusivity Use:||NEW PRODUCT|
|Regulatory Exclusivity Expiration:||Dec 2, 2017
|Regulatory Exclusivity Use:||PEDIATRIC EXCLUSIVITY|
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.